Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. In this article, we are ...

As we always do at Amgen, let's start with our mission to serve patients ... We have momentum with a number of key brands, including Repatha, EVENITY, BLINCYTO and TEZSPIRE which will help drive ...

Amgen’s second-quarter results were strong ... Twelve products, including Prolia, Repatha, Blincyto, Tezspire and Evenity, achieved double-digit volume growth in the quarter.

However, revenues from key older medicines like Prolia, Repatha, Blincyto and new drugs like Tavneos and Tezspire are driving the top line. Amgen is also evaluating Prolia/Xgeva, Repatha ...

Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Amgen Inc. (NASDAQ:AMGN ... to the company’s therapeutic oncology portfolio with the acquisition of Onyx. Repatha (reducing cholesterol), Aimovig (migraine), Lumakras (lung cancer), and Tezspire ...

However, revenues from key older medicines like Prolia, Repatha, Blincyto and new drugs like Tavneos and Tezspire are driving the top line. Amgen is also evaluating Prolia/Xgeva, Repatha, Otezla, ...